Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
24.51
-1.99 (-7.51%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Evommune Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Market Capitalization | 883 | 540 | - | - |
| Enterprise Value | 780 | 721 | - | - |
| Last Close Price | 26.50 | 17.12 | - | - |
| PS Ratio | 71.34 | 41.52 | - | - |
| PB Ratio | 4.06 | 2.63 | - | - |
| P/TBV Ratio | 4.51 | 2.63 | - | - |
| EV/Sales Ratio | 59.99 | 55.49 | - | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.03 | 0.02 |
| Net Debt / Equity Ratio | -0.72 | -0.72 | -1.49 | -1.09 |
| Net Debt / EBITDA Ratio | 1.85 | 1.85 | 1.03 | 2.11 |
| Net Debt / FCF Ratio | 1.93 | 1.93 | 1.21 | 2.59 |
| Asset Turnover | 0.09 | 0.09 | 0.09 | - |
| Quick Ratio | 8.33 | 8.33 | 2.58 | 11.53 |
| Current Ratio | 8.57 | 8.57 | 2.64 | 11.67 |
| Return on Equity (ROE) | -54.42% | -54.42% | -112.09% | - |
| Return on Assets (ROA) | -33.67% | -33.67% | -55.28% | - |
| Return on Capital Employed (ROCE) | -39.20% | -39.20% | -145.60% | -50.20% |
| Earnings Yield | -7.43% | -12.76% | - | - |
| FCF Yield | -8.27% | -14.21% | - | - |
| Buyback Yield / Dilution | -306.86% | -306.85% | -20.35% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.